Raymond James & Associates’s DS HEALTHCARE GROUP, INC. NEW COMMON STOCK DSKX Stock Holding History

Raymond James & Associates’s Portfolio DSKX Stock Details DSKX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-47,976	Closed	-$1K	–	3486
2016 Q3	$1K	Hold	47,976	–	–	﹤0.01%	3213
2016 Q2	$6K	Hold	47,976	–	–	﹤0.01%	2989
2016 Q1	$37K	Buy	+47,976	New	+$78.8K	﹤0.01%	2812

Other funds holding DSKX

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Raymond James & Associates's DSKX Position: Q4 2016 in Review

Raymond James & Associates sold out of DS HEALTHCARE GROUP, INC. NEW COMMON STOCK (DSKX) in Q4 2016, closing a stake of 47,976 shares — an estimated $1K sold.

Raymond James & Associates first reported a position in DSKX in Q1 2016 and held it in 3 quarters. The position peaked at $37K in Q1 2016. 2 funds tracked by Wall St. Rank hold DSKX as of Q4 2016.

Raymond James & Associates reported no remaining DS HEALTHCARE GROUP, INC. NEW COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Raymond James & Associates sold 47,976 DS HEALTHCARE GROUP, INC. NEW COMMON STOCK shares in Q4 2016, an estimated $1K.
Raymond James & Associates first reported a position in DS HEALTHCARE GROUP, INC. NEW COMMON STOCK in Q1 2016 and held it in 3 quarters.
Raymond James & Associates's DS HEALTHCARE GROUP, INC. NEW COMMON STOCK position peaked at $37K in Q1 2016.
2 funds tracked by Wall St. Rank held DS HEALTHCARE GROUP, INC. NEW COMMON STOCK as of Q4 2016.

Based on Raymond James & Associates's 13F filing for Q4 2016, filed 14 Feb 2017.